UniProt ID | ROA2_MOUSE | |
---|---|---|
UniProt AC | O88569 | |
Protein Name | Heterogeneous nuclear ribonucleoproteins A2/B1 | |
Gene Name | Hnrnpa2b1 | |
Organism | Mus musculus (Mouse). | |
Sequence Length | 353 | |
Subcellular Localization | Nucleus, nucleoplasm . Cytoplasmic granule . Secreted, exosome . Localized in cytoplasmic mRNP granules containing untranslated mRNAs. Component of ribonucleosomes. Not found in the nucleolus. Found in exosomes follwong sumoylation. | |
Protein Description | Heterogeneous nuclear ribonucleoprotein (hnRNP) that associates with nascent pre-mRNAs, packaging them into hnRNP particles. The hnRNP particle arrangement on nascent hnRNA is non-random and sequence-dependent and serves to condense and stabilize the transcripts and minimize tangling and knotting. Packaging plays a role in various processes such as transcription, pre-mRNA processing, RNA nuclear export, subcellular location, mRNA translation and stability of mature mRNAs. Forms hnRNP particles with at least 20 other different hnRNP and heterogeneous nuclear RNA in the nucleus. Involved in transport of specific mRNAs to the cytoplasm in oligodendrocytes and neurons: acts by specifically recognizing and binding the A2RE (21 nucleotide hnRNP A2 response element) or the A2RE11 (derivative 11 nucleotide oligonucleotide) sequence motifs present on some mRNAs, and promotes their transport to the cytoplasm (By similarity). Specifically binds single-stranded telomeric DNA sequences, protecting telomeric DNA repeat against endonuclease digestion (By similarity). Also binds other RNA molecules, such as primary miRNA (pri-miRNAs): acts as a nuclear 'reader' of the N6-methyladenosine (m6A) mark by specifically recognizing and binding a subset of nuclear m6A-containing pri-miRNAs. Binding to m6A-containing pri-miRNAs promotes pri-miRNA processing by enhancing binding of DGCR8 to pri-miRNA transcripts. Involved in miRNA sorting into exosomes following sumoylation, possibly by binding (m6A)-containing pre-miRNAs. Acts as a regulator of efficiency of mRNA splicing, possibly by binding to m6A-containing pre-mRNAs (By similarity).. | |
Protein Sequence | MEKTLETVPLERKKREKEQFRKLFIGGLSFETTEESLRNYYEQWGKLTDCVVMRDPASKRSRGFGFVTFSSMAEVDAAMAARPHSIDGRVVEPKRAVAREESGKPGAHVTVKKLFVGGIKEDTEEHHLRDYFEEYGKIDTIEIITDRQSGKKRGFGFVTFDDHDPVDKIVLQKYHTINGHNAEVRKALSRQEMQEVQSSRSGRGGNFGFGDSRGGGGNFGPGPGSNFRGGSDGYGSGRGFGDGYNGYGGGPGGGNFGGSPGYGGGRGGYGGGGPGYGNQGGGYGGGYDNYGGGNYGSGSYNDFGNYNQQPSNYGPMKSGNFGGSRNMGGPYGGGNYGPGGSGGSGGYGGRSRY | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
1 | Acetylation | -------MEKTLETV -------CCCCCCCC | 12.29 | - | |
4 | Phosphorylation | ----MEKTLETVPLE ----CCCCCCCCCCH | 19.27 | 29514104 | |
17 (in isoform 3) | Phosphorylation | - | 61.93 | 29514104 | |
17 (in isoform 2) | Phosphorylation | - | 61.93 | 29514104 | |
17 | Ubiquitination | LERKKREKEQFRKLF CHHHHHHHHHHHHHH | 61.93 | 27667366 | |
22 | Ubiquitination | REKEQFRKLFIGGLS HHHHHHHHHHCCCCC | 49.38 | 22790023 | |
29 | Phosphorylation | KLFIGGLSFETTEES HHHCCCCCCCCCHHH | 25.06 | 26239621 | |
32 | Phosphorylation | IGGLSFETTEESLRN CCCCCCCCCHHHHHH | 37.18 | 26239621 | |
33 | Phosphorylation | GGLSFETTEESLRNY CCCCCCCCHHHHHHH | 30.47 | 26239621 | |
38 | Methylation | ETTEESLRNYYEQWG CCCHHHHHHHHHHHC | 38.08 | 24129315 | |
46 | Acetylation | NYYEQWGKLTDCVVM HHHHHHCCCEEEEEE | 45.30 | 22826441 | |
46 | Ubiquitination | NYYEQWGKLTDCVVM HHHHHHCCCEEEEEE | 45.30 | 22790023 | |
50 | S-nitrosocysteine | QWGKLTDCVVMRDPA HHCCCEEEEEECCCC | 1.78 | - | |
50 | S-palmitoylation | QWGKLTDCVVMRDPA HHCCCEEEEEECCCC | 1.78 | 28526873 | |
50 | S-nitrosylation | QWGKLTDCVVMRDPA HHCCCEEEEEECCCC | 1.78 | 24926564 | |
59 | Ubiquitination | VMRDPASKRSRGFGF EECCCCCCCCCCCEE | 57.40 | 22790023 | |
59 | Acetylation | VMRDPASKRSRGFGF EECCCCCCCCCCCEE | 57.40 | 68671 | |
68 | Phosphorylation | SRGFGFVTFSSMAEV CCCCEEEEEHHHHHH | 18.62 | 25890499 | |
70 | Phosphorylation | GFGFVTFSSMAEVDA CCEEEEEHHHHHHHH | 15.16 | 25777480 | |
71 | Phosphorylation | FGFVTFSSMAEVDAA CEEEEEHHHHHHHHH | 20.16 | 25777480 | |
85 | Phosphorylation | AMAARPHSIDGRVVE HHHCCCCCCCCEECC | 25.67 | 23684622 | |
99 | Methylation | EPKRAVAREESGKPG CCCCHHHHHHCCCCC | 41.43 | 58857861 | |
100 | Ubiquitination | PKRAVAREESGKPGA CCCHHHHHHCCCCCC | 46.94 | 27667366 | |
102 | Phosphorylation | RAVAREESGKPGAHV CHHHHHHCCCCCCEE | 47.57 | 23684622 | |
104 | Methylation | VAREESGKPGAHVTV HHHHHCCCCCCEEEE | 49.94 | - | |
104 | Malonylation | VAREESGKPGAHVTV HHHHHCCCCCCEEEE | 49.94 | 26320211 | |
104 | Acetylation | VAREESGKPGAHVTV HHHHHCCCCCCEEEE | 49.94 | 23806337 | |
104 | Ubiquitination | VAREESGKPGAHVTV HHHHHCCCCCCEEEE | 49.94 | - | |
104 | "N6,N6-dimethyllysine" | VAREESGKPGAHVTV HHHHHCCCCCCEEEE | 49.94 | - | |
112 | Ubiquitination | PGAHVTVKKLFVGGI CCCEEEEEEEEECCC | 34.10 | 22790023 | |
112 | Acetylation | PGAHVTVKKLFVGGI CCCEEEEEEEEECCC | 34.10 | 22826441 | |
113 | Acetylation | GAHVTVKKLFVGGIK CCEEEEEEEEECCCC | 42.70 | 22826441 | |
113 | Ubiquitination | GAHVTVKKLFVGGIK CCEEEEEEEEECCCC | 42.70 | 22790023 | |
120 | Ubiquitination | KLFVGGIKEDTEEHH EEEECCCCCCCCHHH | 53.46 | - | |
120 | Acetylation | KLFVGGIKEDTEEHH EEEECCCCCCCCHHH | 53.46 | 23806337 | |
120 | Succinylation | KLFVGGIKEDTEEHH EEEECCCCCCCCHHH | 53.46 | - | |
120 | Malonylation | KLFVGGIKEDTEEHH EEEECCCCCCCCHHH | 53.46 | 26320211 | |
123 | Phosphorylation | VGGIKEDTEEHHLRD ECCCCCCCCHHHHHH | 44.35 | 24899341 | |
137 | Ubiquitination | DYFEEYGKIDTIEII HHHHHHCCCCEEEEE | 36.19 | - | |
140 | Phosphorylation | EEYGKIDTIEIITDR HHHCCCCEEEEEECC | 24.79 | 29514104 | |
145 | Phosphorylation | IDTIEIITDRQSGKK CCEEEEEECCCCCCC | 30.69 | 28066266 | |
149 | Phosphorylation | EIITDRQSGKKRGFG EEEECCCCCCCCEEE | 54.17 | 28066266 | |
152 | Ubiquitination | TDRQSGKKRGFGFVT ECCCCCCCCEEEEEE | 62.37 | 22790023 | |
159 | Phosphorylation | KRGFGFVTFDDHDPV CCEEEEEEECCCCCH | 21.05 | 29514104 | |
168 | Ubiquitination | DDHDPVDKIVLQKYH CCCCCHHHHHHEEEC | 34.64 | 22790023 | |
168 | Acetylation | DDHDPVDKIVLQKYH CCCCCHHHHHHEEEC | 34.64 | 23806337 | |
173 | Ubiquitination | VDKIVLQKYHTINGH HHHHHHEEECHHCCC | 34.53 | 22790023 | |
173 | Acetylation | VDKIVLQKYHTINGH HHHHHHEEECHHCCC | 34.53 | 22826441 | |
174 | Phosphorylation | DKIVLQKYHTINGHN HHHHHEEECHHCCCC | 7.40 | 25367039 | |
176 | Phosphorylation | IVLQKYHTINGHNAE HHHEEECHHCCCCHH | 17.04 | 23684622 | |
189 | Phosphorylation | AEVRKALSRQEMQEV HHHHHHHCHHHHHHH | 36.46 | 29176673 | |
198 | Phosphorylation | QEMQEVQSSRSGRGG HHHHHHHHHCCCCCC | 32.66 | 24899341 | |
199 | Phosphorylation | EMQEVQSSRSGRGGN HHHHHHHHCCCCCCC | 17.24 | 27742792 | |
200 | Methylation | MQEVQSSRSGRGGNF HHHHHHHCCCCCCCC | 48.67 | 58857851 | |
201 | Phosphorylation | QEVQSSRSGRGGNFG HHHHHHCCCCCCCCC | 34.49 | 22324799 | |
203 | Asymmetric dimethylarginine | VQSSRSGRGGNFGFG HHHHCCCCCCCCCCC | 51.60 | - | |
203 | Methylation | VQSSRSGRGGNFGFG HHHHCCCCCCCCCCC | 51.60 | 24129315 | |
212 | Phosphorylation | GNFGFGDSRGGGGNF CCCCCCCCCCCCCCC | 32.95 | 23684622 | |
213 | Asymmetric dimethylarginine | NFGFGDSRGGGGNFG CCCCCCCCCCCCCCC | 53.14 | - | |
213 | Methylation | NFGFGDSRGGGGNFG CCCCCCCCCCCCCCC | 53.14 | 24129315 | |
225 | Phosphorylation | NFGPGPGSNFRGGSD CCCCCCCCCCCCCCC | 35.61 | 26824392 | |
228 | Methylation | PGPGSNFRGGSDGYG CCCCCCCCCCCCCCC | 53.46 | 24129315 | |
231 | Phosphorylation | GSNFRGGSDGYGSGR CCCCCCCCCCCCCCC | 30.59 | 23684622 | |
234 | Phosphorylation | FRGGSDGYGSGRGFG CCCCCCCCCCCCCCC | 17.07 | 26160508 | |
236 | Phosphorylation | GGSDGYGSGRGFGDG CCCCCCCCCCCCCCC | 19.48 | 26160508 | |
238 | Methylation | SDGYGSGRGFGDGYN CCCCCCCCCCCCCCC | 38.68 | 24129315 | |
244 | Phosphorylation | GRGFGDGYNGYGGGP CCCCCCCCCCCCCCC | 15.34 | 25619855 | |
245 (in isoform 3) | Phosphorylation | - | 42.62 | - | |
247 | Phosphorylation | FGDGYNGYGGGPGGG CCCCCCCCCCCCCCC | 14.68 | 25619855 | |
259 | Phosphorylation | GGGNFGGSPGYGGGR CCCCCCCCCCCCCCC | 18.61 | 27087446 | |
262 | Phosphorylation | NFGGSPGYGGGRGGY CCCCCCCCCCCCCCC | 18.91 | 25619855 | |
266 | Methylation | SPGYGGGRGGYGGGG CCCCCCCCCCCCCCC | 38.34 | 24129315 | |
266 | Asymmetric dimethylarginine | SPGYGGGRGGYGGGG CCCCCCCCCCCCCCC | 38.34 | - | |
306 | Phosphorylation | SYNDFGNYNQQPSNY CCCCCCCCCCCCCCC | 18.09 | - | |
312 (in isoform 2) | Phosphorylation | - | 53.08 | 19144319 | |
318 | Phosphorylation | SNYGPMKSGNFGGSR CCCCCCCCCCCCCCC | 32.49 | 26643407 | |
324 | Phosphorylation | KSGNFGGSRNMGGPY CCCCCCCCCCCCCCC | 22.36 | 19144319 | |
325 | Methylation | SGNFGGSRNMGGPYG CCCCCCCCCCCCCCC | 40.19 | 24129315 | |
331 | Phosphorylation | SRNMGGPYGGGNYGP CCCCCCCCCCCCCCC | 31.51 | 25619855 | |
336 | Phosphorylation | GPYGGGNYGPGGSGG CCCCCCCCCCCCCCC | 28.15 | 25619855 | |
341 | Phosphorylation | GNYGPGGSGGSGGYG CCCCCCCCCCCCCCC | 45.99 | 25521595 | |
344 | Phosphorylation | GPGGSGGSGGYGGRS CCCCCCCCCCCCCCC | 32.35 | 23684622 | |
347 | Phosphorylation | GSGGSGGYGGRSRY- CCCCCCCCCCCCCC- | 21.67 | 27149854 | |
350 | Methylation | GSGGYGGRSRY---- CCCCCCCCCCC---- | 17.38 | 24129315 | |
351 | Phosphorylation | SGGYGGRSRY----- CCCCCCCCCC----- | 38.92 | 22705319 | |
352 | Methylation | GGYGGRSRY------ CCCCCCCCC------ | 39.56 | 18966523 | |
353 | Phosphorylation | GYGGRSRY------- CCCCCCCC------- | 24.93 | 26643407 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of ROA2_MOUSE !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of ROA2_MOUSE !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
SET_MOUSE | Set | physical | 16170352 | |
PP2AA_MOUSE | Ppp2ca | physical | 16170352 |
Kegg Drug | ||||||
---|---|---|---|---|---|---|
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"The phagosomal proteome in interferon-gamma-activated macrophages."; Trost M., English L., Lemieux S., Courcelles M., Desjardins M.,Thibault P.; Immunity 30:143-154(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-324, AND MASSSPECTROMETRY. | |
"Solid tumor proteome and phosphoproteome analysis by high resolutionmass spectrometry."; Zanivan S., Gnad F., Wickstroem S.A., Geiger T., Macek B., Cox J.,Faessler R., Mann M.; J. Proteome Res. 7:5314-5326(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-85, AND MASSSPECTROMETRY. | |
"Specific phosphopeptide enrichment with immobilized titanium ionaffinity chromatography adsorbent for phosphoproteome analysis."; Zhou H., Ye M., Dong J., Han G., Jiang X., Wu R., Zou H.; J. Proteome Res. 7:3957-3967(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-259, AND MASSSPECTROMETRY. |